Pacira reported $10.23M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Astellas Pharma JPY 92.54B 137.02B Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 6.94B 443M Jun/2025
Ligand Pharmaceuticals USD 43.56M 92.88M Jun/2025
Novo Nordisk 34.08B 4.71B Jun/2025
Pacira USD 10.23M 2.21M Jun/2025
Perrigo USD 55.6M 91M Jun/2025
Pfizer USD 2.6B 3.33B Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025
Teva Pharmaceutical Industries USD 406M 540M Jun/2025
Xeris Pharmaceuticals USD 5.43M 3.75M Jun/2025
Zoetis USD 1.02B 106M Jun/2025